An in vitro method for estimation of arsenic relative bioavailability in soil

Oral bioaccessibility of PTEs in soils: A review of data, influencing factors and application in human health risk assessment

Understanding the behavior of metal(loi)ds transported from soil to humans is critical for human health risk assessment (HHRA). In the last two decades, extensive studies have been conducted to better assess human exposure to potentially toxic elements (PTEs) by estimating their oral bioaccessibility (BAc) and quantifying the influence of different factors. This study reviews the common in vitro methods used to determine the BAc of PTEs (in particular As, Cd, Cr, Ni, Pb, and Sb) under specific conditions (particularly in terms of the particle size fraction and validation status against an in vivo model). The results were compiled from soils derived from various sources and allowed the identification of the most important influencing factors of BAc (using single and multiple regression analyses), including physicochemical soil properties and the speciation of the PTEs in question. This review presents current knowledge on integrating relative bioavailability (RBA) in calculating doses from soil ingestion in the HHRA process. Depending on the jurisdiction, validated or non-validated bioaccessibility methods were used, and risks assessors applied different approaches: (i) using default assumptions (i.e., RBA of 1); (ii) considering that bioaccessibility value (BAc) accurately represents RBA (i.e., RBA equal to BAc); (iii) using regression models to convert BAc of As and Pb into RBA as proposed by the USA with the US EPA Method 1340; or (iv) applying an adjustment factor as proposed by the Netherlands and France to use BAc from UBM (Unified Barge Method) protocol. The findings from this review should help inform risk stakeholders about the uncertainties surrounding using bioaccessibility data and provide recommendations for better interpreting the results and using bioaccessibility in risk studies.

A global meta-analysis of the correlation between soil physicochemical properties and lead bioaccessibility

Soil physiochemical properties play a vital role in bioaccessibility-based health risk assessment as it can determine the bioaccessibility and the true risk of potentially toxic elements in soil. However, the effects of soil properties on bioaccessibility still remains unclear. In this paper, 17 of the 1454 literatures with 474 samples were identified, screened and reviewed for exploring the correlation between soil physicochemical properties and lead bioaccessibility (BAc_Pb) through a meta-analysis approach. Five soil physicochemical parameters including pH, SOM, Clay, CEC and T-Pb were systematically analyzed using Principal component analysis, Pearson correlation analysis and survival analysis. The results showed that pH of simulated gastric juice is a major source of heterogeneity of the correlation between soil pH and BAc_Pb. In the gastric phase, the effect of alkaline soil on high BAc_Pb (BAc >50%) is more sensitive, and the effect of acidic soil on low BAc_Pb (BAc <50%) is more sensitive. However, in the small intestinal phase, soil pH displays little impacts on BAc_Pb in acidic, alkaline and neutral soils. Although three principal components explained 66.2% and 64.9% of the total variance of the urban, agricultural, and mining soils in gastric and small intestinal phases, respectively, there was no strong evidence that soil type can influence the BAc_Pb. The results of present study provide insights into the correlation between soil properties and BAc_Pb, and prediction of the bioaccessibility and bioavailability of Pb in different types of soil.

Innovative accumulative risk assessment strategy of co-exposure of As and Pb in medical earthworms based on in vivo-in vitro correlation

Recent studies on risks assessment of heavy metal(loid) are usually based on their total concentrations. Nevertheless, such an analysis does not assess their real amounts absorbed by human body. To scientifically assess the health risks, in this study medical earthworms were analyzed for relative bioavailability (RBA) of arsenic (As) and lead (Pb) using a multiple gavage mouse model with liver, kidneys, brain, and leg bones as biomarkers for the first time. Metal(loid) bioaccessibility was determined using in vitro physiologically based extraction (PBET) assay. We are the first to develop a novel accumulative health risk assessment strategy by combinational analyzing bioavailability of heavy metal(loid) levels to calculate target organ toxicity dose (TTD) modification of the HI and total cancer risk (TCR), which has capacity to evaluate the health risks of co-exposure of Pb and As in medical earthworms. As a result, As-RBA ranged from 7.2% to 45.1%, and Pb-RBA ranged from 16.1% to 49.8%. Additionally, As and Pb bioaccessibility varied from 6.7% to 48.3% and 7.8% to 52.5%, respectively. Moreover, strong in vivo-in vitro correlations (IVIVCs) were observed between metal-RBA and bioaccessibility, indicating the robustness of the in vitro PBET assay to predict metal-RBA in medical earthworms. The refined accumulative assessment strategy revealed that when adjusted by heavy metal(loid) bioavailability, the TTD modification of HI method typically exhibited an acceptable health risk caused by the co-exposure of Pb and As for cardiovascular, hematological, neurological, and renal system. The TCR levels associated with exposure to Pb and As due to the ingestion of medical earthworms were also acceptable after adjustment by bioavailability. Collectively, our innovation on accumulative risk assessment based on in vivo-in vitro correlation provides a novel approach engaging in assessing the risks due to co-exposure of As and Pb in medical earthworms.

Effect of soil particle size and extraction method on the oral bioaccessibility of arsenic

Recent findings indicate that incidental ingestion of soil by humans primarily involves soil particles <150 µm, rather than <250 µm-sized fraction previously used for most oral bioaccessibility and bioavailability studies. It was postulated that a greater soil surface area in the finer fraction (<150 versus <250 µm) might increase oral bioaccessibility of arsenic (As) in soil. Bioaccessibility and concentrations of As were compared in <150 and <250 µm fractions of 18 soil samples from a variety of arsenic-contaminated sites. The two methods used to measure bioaccessibility were compared - EPA Method 1340 and the California Arsenic Bioaccessibility (CAB) method. Arsenic concentrations were nearly the same or higher in the <150 fraction compared with <250 µm. EPA Method 1340 and the CAB method presented significantly different bioaccessibility results, as well as estimated relative oral bioavailability (RBA) based upon algorithms specific to the methods, but there was no marked difference for <150 and <250 µm soil fractions within either method. When compared with RBA determined previously for these soil samples in vivo in non-human primates, EPA Method 1340 was generally more predictive than the CAB method. Data suggest that soil- or site-specific factors control bioaccessibility under either method and that the test method selected is more important than the particle size fraction (<150 or <250) in using these in vitro methods to predict As RBA for use in risk assessment.

In situ stabilization of arsenic and lead in contaminated soil using iron-rich water treatment residuals

Arsenic (As) and lead (Pb) are common soil contaminants, environmentally hazardous, and threats to public health. Addition of soluble phosphate is known to be effective for in situ remediation of Pb-contaminated soils, but phosphate additions displace As from the soil particles and increase As concentration in soil solution. This study examined the dual use of iron (Fe) and phosphorus (P) amendments to soil that was highly contaminated with As and Pb. The test soil originated from a former smelter site in Utah with As and Pb concentrations of 66,400 mg Pb kg^-1 and 7,520 mg As kg^-1 . Goethite, ferrihydrite, and Fe-rich water treatment residuals (Fe-WTRs) were added to immobilize As, and soluble P was added to reduce Pb lability. The Fe amendments were added in Fe/As molar ratios ranging from 1:1 to 1:10, and P was added in P/Pb molar ratios ranging from 0.2:1 to 5:1. Iron-rich water treatment residuals were found to be the most effective Fe amendment. When Fe-WTR and P were added simultaneously, the P concentrations required to immobilize Pb resulted in increased mobilization of As, even when Fe-WTR were added at 10:1 Fe/As. However, when P was added first at 5:1 P/Pb, incubated for 1 wk, and then amended with Fe-WTR at 10:1 Fe/As, both Pb and As were significantly immobilized. The proposed process is a practical remediation approach to soils co-contaminated with Pb and As while encouraging re-use of Fe-WTR as a sustainable amendment.

Interconnected soil iron and arsenic speciation effects on arsenic bioaccessibility and bioavailability: a scoping review

Extensive research has examined arsenic (As) bioavailability in contaminated soils and is routinely assessed using in vitro bioaccessibility (IVBA) assays. Analysis of differences in bioaccessibility measurements across IVBA assays and phases is expected to provide valuable insights into geochemical mechanisms controlling soil As bioaccessibility and bioavailability. Soil iron (Fe) content and As speciation are expected to significantly influence IVBA gastric and intestinal phases due to fluctuations in precipitation-dissolution chemistry and sorption reactivity as pH and assay chemical complexity changes. The aim of this review was to examine these relationships by 1) conducting a meta-analysis (n = 47 soils) determining the influence of total Fe on As bioaccessibility measurements and 5 IVBA assays and 2) investigating the effect of As speciation on gastric/intestinal phase IVBA and in vitro-in vivo correlations. Our findings indicate that soil Fe content and As speciation heterogeneity are important in elucidating variability of bioaccessibility measurements across IVBA assays and gastrointestinal phases. Greater focus on coupled As speciation and Fe precipitation chemistry may (1) improve our understanding of soil geochemical factors and assay constituents that influence As in vitro-in vivo correlations and (2) resolve variability in the precision of oral relative bioavailability (RBA) estimated using IVBA assays for soils possessing heterogenous As speciation and Fe composition.

Improving the predictive value of bioaccessibility assays and their use to provide mechanistic insights into bioavailability for toxic metals/metalloids - A research prospectus

Widespread contamination of soil, dust, and food with toxic metal(loid)s pose a significant public health concern. Only a portion of orally ingested metal(loid) contaminants are bioavailable, which is defined as the fraction of ingested metal(loid)s absorbed across the gastrointestinal barrier and into systemic circulation. Bioaccessibility tools are a class of in vitro assays used as a surrogate to estimate risk of oral exposure and bioavailability. Although development and use of bioaccessibility tools have contributed to our understanding of the factors influencing oral bioavailability of metal(loid)s, some of these assays may lack data that support their use in decisions concerning adverse health risks and soil remediation. This review discusses the factors known to influence bioaccessibility of metal(loid) contaminants and evaluates experimental approaches and key findings of SW-846 Test Method 1340, Unified BARGE Method, Simulated Human Intestinal Microbial Ecosystem, Solubility Bioaccessibility Research Consortium assay, In Vitro Gastrointestinal model, TNO-Gastrointestinal Model, and Dutch National Institute for Public Health and the Environment bioaccessibility models which are used to assess oral absolute bioavailability and relative bioavailability in solid matrices. The aim of this review was to identify emerging knowledge gaps and research needs with an emphasis on research required to evaluate these models on (1) standardization of assay techniques and methodology, and (2) use of common criteria for assessing the performance of bioaccessibility models.

Evaluation of single-extraction methods to estimate the oral bioaccessibility of metal(loid)s in soils

Incidental ingestion of polluted soil particles exposes the population to toxic metal(loid)s. To refine the methods of exposure and risk assessment, it is relevant to use bioaccessible concentrations of metal(loid)s determined via in vitro digestion methods. However, some validated methods are complex and costly, involving high technical skills and numerous reagents. The objective of the present study was to evaluate the suitability of four simple chemical extractions to mimic the bioaccessible fraction of As, Cd, and Pb in the gastric (G) and gastrointestinal (GI) phases obtained using the validated UBM (unified bioaccessibility method) test. Acetic acid (0.11 M), citric acid (0.11 M), EDTA (0.16 M), and hydrochloric acid (HCl, 0.65%) were separately tested in 201 soil samples with a wide range of physicochemical parameters and metal(loid)s concentrations. Significant linear relationships were observed with HCl, EDTA, and to a lesser extent with citric acid. For the cheaper HCl method, correlations with the UBM ranged from 0.91 to 0.99 for the G phase and from 0.72 to 0.97 for the GI phase. This test can be used at least as a first-tier screening to assess the oral bioaccessibility of As, Cd, and Pb.

Remediation of an urban garden with elevated levels of soil contamination

Urban gardening is popular in many cities. However, many urban soils are contaminated and pose risks to human health. This study was conducted in a highly publicized urban garden in Brooklyn, NY with elevated Pb and As levels. Our objectives were to: (1) assess the nature and extent of Pb and As contamination at this site; (2) evaluate the effectiveness of amendments on reducing the bioaccessibility and phytoavailability of Pb and As in soil; and (3) assess the potential exposure of children to Pb and As through direct and indirect exposure pathways. Field surveys of the site revealed that contamination was highly concentrated in one area of the garden associated with fruit tree production. Field plots were established in this area, with three different treatments (bone meal, compost, sulfur) and an unamended control. Bioaccessibility of Pb was significantly reduced by all three treatments compared to the control (33%): bone meal (24%), compost (23%), sulfur (24%). In this study, As bioaccessibility remained high (80-93%) with or without treatments. We found that the effectiveness of soil remediation with amendments is variable and often limited, and contaminated sites can still pose a significant risk to urban gardeners. The results of a simple assessment model suggested that Pb and As exposure was mostly from soil and dust ingestion, rather than vegetable consumption. This work is unique in that it evaluates actual elevated levels of contamination, in actively gardened urban soils, in a highly visible public context. It fills important gaps between basic research and analysis of human exposure to toxic trace metals that can be a constraint on a highly beneficial activity.

Oral Bioavailability of As, Pb, and Cd in Contaminated Soils, Dust, and Foods based on Animal Bioassays: A Review

Metal contamination in soil, dust, and food matrices impacts the health of millions of people worldwide. During the past decades, various animal bioassays have been developed to determine the relative bioavailability (RBA) of As, Pb, and Cd in contaminated soils, dust, and foods, which vary in operational approaches. This review discusses the strengths and weaknesses of different animal models (swine and mice), dosing schemes (single gavage dose, repeated gavage dose, daily repeated feeding, and free access to diet), and end points (blood, urine, and tissue) in metal-RBA measurement; compares metal-RBA obtained using mouse and swine bioassays, different dosing schemes, and different end points; and summarizes key findings on As-, Pb-, and Cd-RBA values in contaminated soils, dust, and foods. Future directions related to metal-RBA research are highlighted, including (1) comparison of metal-RBA determinations between different bioassays and different laboratories to ensure robust bioavailability data, (2) enhancing the metal-RBA database for contaminated dust and foods, (3) identification of physiological and physicochemical mechanisms responsible for variability in metal-RBA values, (4) formulation of strategies to decrease metal-RBA values in contaminated soils, dust, and foods, and (5) assessing the impacts of cocontaminants on metal-RBA measurement.

Arsenic Speciation of Contaminated Soils / Solid Wastes and Relative Oral Bioavailability in Swine and Mice

Arsenic (As) is one of the most widespread, toxic elements in the environment and human activities have resulted in a large number of contaminated areas. However abundant, the potential of As toxicity from exposure to contaminated soils is limited to the fraction that will dissolve in the gastrointestinal system and be absorbed into systemic circulation or bioavailable species. In part, the release of As from contaminated soil to gastrointestinal fluid depends on the form of solid phase As also termed “As speciation.” In this study, 27 As-contaminated soils and solid wastes were analyzed using X-ray absorption spectroscopy (XAS) and results were compared to in vivo bioavailability values determined using the adult mouse and juvenile swine bioassays. Arsenic bioavailability was lowest for soils that contained large amounts of arsenopyrite and highest for materials that contained large amounts of ferric arsenates. Soil and solid waste type and properties rather than the contamination source had the greatest influence on As speciation. Principal component analysis determined that As(V) adsorbed and ferric arsenates were the dominant species that control As speciation in the selected materials. Multiple linear regression (MLR) was used to determine the ability of As speciation to predict bioavailability. Arsenic speciation was predictive of 27% and 16% of RBA As determined using the juvenile swine and adult mouse models, respectively. Arsenic speciation can provide a conservative estimate of RBA As using MLR for the juvenile swine and adult mouse bioassays at 55% and 53%, respectively.

Total and Bioaccessible Soil Arsenic and Lead Levels and Plant Uptake in Three Urban Community Gardens in Puerto Rico

Arsenic (As) and lead (Pb) are two contaminants of concern associated with urban gardening. In Puerto Rico, data currently is limited on As and Pb levels in urban garden soils, soil metal (loid) bioaccessibility, and uptake of As and Pb in soil by edible plants grown in the region. This study examined total and bioaccessible soil As and Pb concentrations and accumulation in 10 commonly grown garden plants collected from three urban community gardens in Puerto Rico. Bioavailability values were predicted using bioaccessibility data to compare site-specific bioavailability estimates to commonly used default exposure assumptions. Total and bioaccessible As levels in study soils ranged from 2 to 55 mg/kg and 1 to 18 mg/kg, respectively. Total and bioaccessible Pb levels ranged from 19 to 172 mg/kg and 17 to 97 mg/kg, respectively. Measured bioaccessibility values corresponded to 19 to 42% bioaccessible As and 61 to 100% bioaccessible Pb when expressed as a percent of total As and Pb respectively. Predicted relative percent bioavailability of soil As and Pb based on measured bioaccessibility values ranged from 18 to 36% and 51 to 85% for As and Pb respectively. Transfer factors (TFs) measuring uptake of As in plants from soil ranged from 0 to 0.073 in the edible flesh (fruit or vegetable) of plant tissues analyzed and 0.073 to 0.444 in edible leaves. Pb TFs ranged from 0.002 to 0.012 in flesh and 0.023 to 0.204 in leaves. Consistent with TF values, leaves accumulated higher concentrations of As and Pb than the flesh, with the highest tissue concentrations observed in the culantro leaf (3.2 mg/kg dw of As and 8.9 mg/kg dw of Pb). Leaves showed a general but not statistically-significant (α = 0.05) trend of increased As and Pb concentration with increased soil levels, while no trend was observed for flesh tissues. These findings provide critical data that can improve accuracy and reduce uncertainty when conducting site-specific risk determination of potential As and Pb exposure while gardening or consuming garden produce in the understudied region of Puerto Rico.

Relating soil geochemical properties to arsenic bioaccessibility through hierarchical modeling

Interest in improved understanding of relationships among soil properties and arsenic (As) bioaccessibility has motivated the use of regression models for As bioaccessibility prediction. However, limits in the numbers and types of soils included in previous studies restrict the usefulness of these models beyond the range of soil conditions evaluated, as evidenced by reduced predictive performance when applied to new data. In response, hierarchical models that consider variability in relationships among soil properties and As bioaccessibility across geographic locations and contaminant sources were developed to predict As bioaccessibility in 139 soils on both a mass fraction (mg/kg) and % basis. The hierarchical approach improved the estimation of As bioaccessibility in studied soils. In addition, the number of soil elements identified as statistically significant explanatory variables increased when compared to previous investigations. Specifically, total soil Fe, P, Ca, Co, and V were significant explanatory variables in both models, while total As, Cd, Cu, Ni, and Zn were also significant in the mass fraction model and Mg was significant in the % model. This developed hierarchical approach provides a novel tool to (1) explore relationships between soil properties and As bioaccessibility across a broad range of soil types and As contaminant sources encountered in the environment and (2) identify areas of future mechanistic research to better understand the complexity of interactions between soil properties and As bioaccessibility.

In vivo and in vitro methods for evaluating soil arsenic bioavailability: relevant to human health risk assessment

Arsenic (As) is the most frequently occurring contaminant on the priority list of hazardous substances, which lists substances of greatest public health concern to people living at or near U.S. National Priorities List site. Accurate assessment of human health risks from exposure to As-contaminated soils depends on estimating its bioavailability, defined as the fraction of ingested As absorbed across the gastrointestinal barrier and available for systemic distribution and metabolism. Arsenic bioavailability varies among soils and is influenced by site-specific soil physical and chemical characteristics and internal biological factors. This review describes the state-of-the science that supports our understanding of oral bioavailability of soil As, the methods that are currently being explored for estimating soil As relative bioavailability (RBA), and future research areas that could improve our prediction of the oral RBA of soil As in humans. The following topics are addressed: (1) As soil geochemistry; (2) As toxicology; (3) in vivo models for estimating As RBA; (4) in vitro bioaccessibility methods; and (5) conclusions and research needs.

Modification of an existing in vitro method to predict relative bioavailable arsenic in soils

The soil matrix can sequester arsenic (As) and reduces its exposure by soil ingestion. In vivo dosing studies and in vitro gastrointestinal (IVG) methods have been used to predict relative bioavailable (RBA) As. Originally, the Ohio State University (OSU-IVG) method predicted RBA As for soils exclusively from mining and smelting sites with a median of 5,636 mg As kg^-1. The objectives of the current study were to (i) evaluate the ability of the OSU-IVG method to predict RBA As for As contaminated soils with a wider range of As content and As contaminant sources, and (ii) evaluate a modified extraction procedure's ability to improve prediction of RBA As. In vitro bioaccessible (IVBA) by OSU-IVG and California Bioaccessibility Method (CAB) methods, RBA As, speciation, and properties of 33 As contaminated soils were determined. Total As ranged from 162 to 12,483 mg kg^-1 with a median of 73 mg kg^-1. RBA As ranged from 1.30 to 60.0% and OSU-IVG IVBA As ranged from 0.80 to 52.3%. Arsenic speciation was predominantly As(V) adsorbed to hydrous ferric oxide (HFO) or iron (Fe), manganese (Mn), and aluminum (Al) oxides. The OSU-IVG often extracted significantly less As in vitro than in vivo RBA As, in particularly for soils from historical gold mining. The CAB method, which is a modified OSU-IVG method extracted more As than OSU-IVG for most soils, resulting in a more accurate predictor than OSU-IVG, especially for low to moderately contaminated soils (<1,500 mg As kg^-1) with RBA As = 0.81 IVBA As + 3.2, r² = 0.91.

Variability of arsenic bioaccessibility and metabolism in soils by human gut microbiota using different in vitro methods combined with SHIME

Arsenic (As) speciation analysis is essential when evaluating the risks upon oral exposure to As-contaminated soils. In this study, we first investigated the variability in the As bioaccessibility and speciation using a combination of five common in vitro methods (SBRC, PBET, DIN, UBM and IVG) (gastric and small intestinal phases) and the SHIME model (colon phase). Our results indicate that the As bioaccessibility varies in the colon phase. An increase in the As bioaccessibility for SBRC and PBET, and a decrease for UBM and IVG were observed in the colon phase. In addition, we found different extents of methylation and large amounts of arsenite [As(III)] due to microbial reduction in the colon digests. The UBM-SHIME method displayed a higher methylation percentage of 13.5-82.1%, but a lower methylation percentage of 0.2-21.8% was observed in the SBRC-SHIME method. Besides, The MMA(V) levels in the colon digests were positively correlated with those of As(III) and DMA(V), so DMA(V) can be considered an indicator to evaluate the As metabolic speed of in vitro cultured human gut microbiota. Based on the standard reference soil of NIST 2710a, the As bioaccessibility in the colon phase of PBET-SHIME and SBRC-SHIME were the closest to the in vivo results. Combining in vitro methods and SHIME will remarkably affect the accurate assessment of potential risks to human health associated with oral exposure to soil As.

Assessment of arsenic speciation and bioaccessibility in mine-impacted materials

Mine-impacted materials were collected from Victoria, Australia and categorized into three source materials; tailings (n=35), calcinated (n=10) and grey slimes (n=5). Arsenic (As) concentrations in these materials varied over several orders of magnitude (30-47,000mgkg(-1)), with median concentrations of 500, 10,800 and 1500mgkg(-1), respectively. When As bioaccessibility was assessed using the Solubility Bioaccessibility Research Consortium (SBRC) assay, As bioaccessibility ranged between 4 and 90%, with mean gastric phase values of 30%, 49% and 82% for tailings, calcinated and grey slimes, respectively. An analysis of variance (ANOVA) determined that As bioaccessibility was significantly different (P<0.05) between source materials. This was due to differences in As mineralogy, soil particle size as well as the concentration and nature of Fe present. X-ray Absorption Near Edge Structure (XANES) analysis identified arseniosiderite, yukonite, realgar, loellingite and mineral sorbed arsenate species in mine-impacted materials. Despite differences in physicochemical properties, 'mine wastes' are often reported under a generic descriptor. Outcomes from this research highlight that variability in As bioaccessibility can be prescribed to As mineralogy and matrix physicochemical properties, while categorizing samples into sub-groups can provide some notional indication of potential exposure.

Arsenic and Environmental Health: State of the Science and Future Research Opportunities

BACKGROUND

Exposure to inorganic and organic arsenic compounds is a major public health problem that affects hundreds of millions of people worldwide. Exposure to arsenic is associated with cancer and noncancer effects in nearly every organ in the body, and evidence is mounting for health effects at lower levels of arsenic exposure than previously thought. Building from a tremendous knowledge base with > 1,000 scientific papers published annually with "arsenic" in the title, the question becomes, what questions would best drive future research directions?

OBJECTIVES

The objective is to discuss emerging issues in arsenic research and identify data gaps across disciplines.

METHODS

The National Institutes of Health's National Institute of Environmental Health Sciences Superfund Research Program convened a workshop to identify emerging issues and research needs to address the multi-faceted challenges related to arsenic and environmental health. This review summarizes information captured during the workshop.

DISCUSSION

More information about aggregate exposure to arsenic is needed, including the amount and forms of arsenic found in foods. New strategies for mitigating arsenic exposures and related health effects range from engineered filtering systems to phytogenetics and nutritional interventions. Furthermore, integration of omics data with mechanistic and epidemiological data is a key step toward the goal of linking biomarkers of exposure and susceptibility to disease mechanisms and outcomes.

CONCLUSIONS

Promising research strategies and technologies for arsenic exposure and adverse health effect mitigation are being pursued, and future research is moving toward deeper collaborations and integration of information across disciplines to address data gaps.

CITATION

Carlin DJ, Naujokas MF, Bradham KD, Cowden J, Heacock M, Henry HF, Lee JS, Thomas DJ, Thompson C, Tokar EJ, Waalkes MP, Birnbaum LS, Suk WA. 2016. Arsenic and environmental health: state of the science and future research opportunities. Environ Health Perspect 124:890-899; http://dx.doi.org/10.1289/ehp.1510209.

Oral Bioavailability, Bioaccessibility, and Dermal Absorption of PAHs from Soil-State of the Science

This article reviews the state of the science regarding oral bioavailability, bioaccessibility, and dermal absorption of carcinogenic polycyclic aromatic hydrocarbons (cPAHs) in soil by humans, and discusses how chemical interactions may control the extent of absorption. Derived from natural and anthropomorphic origins, PAHs occur in a limited number of solid and fluid matrices (i.e., PAH sources) with defined physical characteristics and PAH compositions. Existing studies provide a strong basis for establishing that oral bioavailability of cPAHs from soil is less than from diet, and an assumption of 100% relative bioavailability likely overestimates exposure to cPAHs upon ingestion of PAH-contaminated soil. For both the oral bioavailability and dermal absorption studies, the aggregate data do not provide a broad understanding of how different PAH source materials, PAH concentrations, or soil chemistries influence the absorption of cPAHs from soil. This article summarizes the existing studies, identifies data gaps, and provides recommendations for the direction of future research to support new default or site-specific bioavailability adjustments for use in human health risk assessment.

Predicting oral relative bioavailability of arsenic in soil from in vitro bioaccessibility

Several investigations have been conducted to develop in vitro bioaccessibility (IVBA) assays that reliably predict in vivo oral relative bioavailability (RBA) of arsenic (As). This study describes a meta-regression model relating soil As RBA and IVBA that is based upon data combined from previous investigations that examined the relationship between As IVBA and RBA when IVBA was determined using an extraction of soil in 0.4 M glycine at pH 1.5. Data used to develop the model included paired IVBA and RBA estimates for 83 soils from various types of sites such as mining, smelting, and pesticide or herbicide application. The following linear regression model accounted for 87% of the observed variance in RBA (R(2) = .87): RBA(%) = 0.79 × IVBA(%) + 3. This regression model is more robust than previously reported models because it includes a larger number of soil samples, and also accounts for variability in RBA and IVBA measurements made on samples collected from sites contaminated with different As sources and conducted in different labs that have utilized different experimental models for estimating RBA.

Comparison of arsenic bioaccessibility in housedust and contaminated soils based on four in vitro assays

Few studies have assessed As bioaccessibility in housedust using different in vitro assays and compared to those in contaminated soils. We determined As bioaccessibility in 24 housedust samples (4.48-38.2 mg kg(-1)) using SBRC, IVG, DIN, and PBET assays and they averaged 73, 68, 53, and 48% in the gastric phase and 26, 46, 55 and 43% in the intestinal phase of the 4 assays. The corresponding As bioaccessibility in 34 As-contaminated soils (22-6899 mg kg(-1)) were 34, 25, 22, and 22% in the gastric phase and 18, 19, 21, and 20% in the intestinal phase, which was 1.5-2.7 fold lower than those in housedust possibly due to differences in contamination sources and properties. Based on the gastric phase of SBRC assay, As bioaccessibility was 44-96% in housedust and 2.3-80% in soils. Variation in As bioaccessibility among assays was similar for housedust and soils, with SBRC assay providing the highest bioaccessibility in gastric phase. In intestinal phase, dissolved As was probably adsorbed onto precipitated iron oxides, causing a sharp decrease in As bioaccessibility by SBRC assay. Unlike SBRC assay, gastric constituents (pepsin, mucin, phosphate, and citrate) in other 3 assays inhibited As adsorption and/or enhanced As dissolution, leading to greater As bioaccessibility. The greater As bioaccessibility in housedust than soil suggests the potential of greater health risk from As exposure to housedust than soil.

Predicting Arsenic Relative Bioavailability Using Multiple in Vitro Assays: Validation of in Vivo-in Vitro Correlations

In this study, previously established arsenic (As) in vivo-in vitro correlations (IVIVC) were assessed for their validity using an independent data set comprising As relative bioavailability (RBA) and bioaccessibility values for 13 herbicide- and mine-impacted soils. The validation process established the correlation between As RBA (swine model) and bioaccessibility (five in vitro assays), determined whether correlations differed significantly from previous relationships and assessed model bias and error. The capacity of in vitro assays to predict As RBA was demonstrated by the strength of IVIVC; goodness of fit ranged from 0.53 (DIN-I) to 0.74 (UBM-I). When compared to previous IVIVC (Juhasz et al. Environ. Sci. Technol. 2009 , 43 , 9487 ; Juhasz et al. J. Hazard. Mater. 2011 , 197 , 161 ), there was no significant difference (P < 0.01) in the slope and y-intercept for IVG-G, UBM-G, and UBM-I indicating the consistency of these assays for predicting As RBA. However, variability in model bias and prediction error was observed with significantly lower (P < 0.01) error determined for IVG-G suggesting that As RBA predictions using IVG-G may be more robust compared to UBM-G and UBM-I. In contrast, differences in the slope and/or y-intercept were observed for SBRC-I, IVG-I, PBET-G, PBET-I, DIN-G, and DIN-I suggesting that these methodologies may not be suitable for predicting As RBA.

Independent data validation of an in vitro method for the prediction of the relative bioavailability of arsenic in contaminated soils

In vitro bioaccessibility (IVBA) assays estimate arsenic (As) relative bioavailability (RBA) in contaminated soils to improve accuracy in human exposure assessments. Previous studies correlating soil As IVBA with RBA have been limited by the use of few soil types and sources of As, and the predictive value of As IVBA has not been validated using an independent set of As-contaminated soils. In this study, a robust linear model was developed to predict As RBA in mice using IVBA, and the predictive capability of the model was independently validated using a unique set of As-contaminated soils. Forty As-contaminated soils varying in soil type and contaminant source were included in this study, with 31 soils used for initial model development and nine soils used for independent model validation. The initial model reliably predicted As RBA values in the independent data set, with a mean As RBA prediction error of 5.4%. Following validation, 40 soils were used for final model development, resulting in a linear model with the equation RBA = 0.65 × IVBA + 7.8 and an R(2) of 0.81. The in vivo-in vitro correlation and independent data validation presented provide critical verification necessary for regulatory acceptance in human health risk assessment.

Determination of human health risk incorporating experimentally derived site-specific bioaccessibility of arsenic at an old abandoned smelter site

This study was conducted to investigate the contribution of a site-specific bioavailability of arsenic (As) to human health risk at an old abandoned smelter site in Korea. The site was contaminated with As for over 60 years with the same source (As2O3 in flue gas), but concentration and in vitro bioaccessibility (IVBA) of As differed by operable units (OU), which consequently resulted in difference in estimated risk. Soil samples collected from six OUs showed that aqua regia-extractable As concentrations ranged from 9.8 to 52.8mg/kg (average 34.1mg/kg) at OUs 1-5, which had been used as rice paddy field and farmland, and a forest region OU 6 showed much higher As concentrations (14.4-169.8mg/kg, average 85.9mg/kg). IVBA of As, determined from the ratio of Solubility/Bioavailability Research Consortium (SBRC)-extractable As to aqua regia-extractable As had a wide range of values (90th percentile values of 28.2-65.8%). Carcinogenic risk calculated with total soil As concentration was the highest (1.4×10(-4)) at OU 6 and the risk at the other OUs ranged from 3.8×10(-5) to 5.7×10(-5). In contrast, when site-specific relative bioavailability (i.e., IVBA values) was incorporated, the estimated risk was reduced by 29.5-62.0% and the decrease was the highest at OUs 1 and 5 with the lowest IVBA of 28.2%. The results demonstrate that the chemical forms of As may be different although the source of contamination is similar, and site-specific bioavailability affected by the chemical forms is an important factor in determining human health risk.

Correlation of in vivo relative bioavailability to in vitro bioaccessibility for arsenic in household dust from China and its implication for human exposure assessment

Incidental ingestion of household dust is an important arsenic (As) exposure pathway for children. However, compared to soils, assessment of As relative bioavailability (RBA) in household dust is limited. In this study, As-RBA in 12 household dust samples (7–38 mg kg(–1)) was measured using an in vivo mouse model and compared to As bioaccessibility determined using 4 assays [Solubility Bioaccessibility Research Consortium method (SBRC), in vitro gastrointestinal method (IVG), Deutsches Institut für Normunge.V. method (DIN), and physiologically based extraction test (PBET)]. Arsenic RBA ranged from 21.8 ± 1.6 to 85.6 ± 7.2% with samples containing low Fe and high total organic carbon content having higher As-RBA. Strong in vivo–in vitro correlations (IVIVC) were found between As-RBA and As bioaccessibility for SBRC and DIN (r2 = 0.63–0.85), but weaker ones were obtained for IVG and PBET (r2 = 0.29–0.55). The developed IVIVC for SBRC and DIN were used to calculate As-RBA based on As bioaccessibility for an additional 12 household dust samples. Although As bioaccessibility differed significantly (up to 7.7-fold) based on in vitro methods, predicted As-RBA was less variable (up to 3.0-fold) when calculated using As bioaccessibility data and the corresponding IVIVC. Our data suggested that both SBRC and DIN had potential to assess As bioavailability in household dust samples; however, additional research is needed.

Validation of the predictive capabilities of the Sbrc-G in vitro assay for estimating arsenic relative bioavailability in contaminated soils

A number of bioaccessibility methodologies have the potential to act as surrogate measures of arsenic (As) relative bioavailability (RBA), however, validation of the in vivo-in vitro relationship is yet to be established. Validation is important for human health risk assessment in order to ensure robust models for predicting As RBA for refining exposure via incidental soil ingestion. In this study, 13 As-contaminated soils were assessed for As RBA (in vivo swine model) and As bioaccessibility (Solubility Bioaccessibility Research Consortium gastric phase extraction; SBRC-G). In vivo and in vitro data were used to assess the validity of the As RBA-bioaccessibility correlation previously described by Juhasz et al. (2009). Arsenic RBA and bioaccessibility in the 13 soils ranged from 6.8±2.4% to 70.5±6.8% and 5.7±0.3% to 78.4±0.8% respectively with a strong linear relationship (R2=0.75) between in vivo and in vitro assays. When the As in vivo-in vitro correlation was compared that of Juhasz et al. (2009), there was no significant difference (P>0.05) indicating that the relationship between As RBA and As bioaccessibility was consistent thereby demonstrating its validation. For these data, a grouped linear regression model was developed (R2=0.82) with a slope and y-intercept of 0.84 and 3.56 respectively. A number of cross validation methodologies (2-fold, repeat random subsampling, leave one out) were utilized to determine the performance of the linear regression model. Residuals and prediction errors ranged from 5.4 to 9.4 and 6.9-12.2 respectively illustrating the capacity of the SBRC-G to accurately predict As RBA in contaminated soil.

Variability associated with as in vivo-in vitro correlations when using different bioaccessibility methodologies

To evaluate the capabilities of in vitro assays to predict arsenic (As) relative bioavailability (RBA), we examined the relationship between As bioaccessibility, determined using a number of in vitro bioaccessibility (IVBA) methodologies (SBRC, IVG, PBET, DIN and UBM) and As RBA determined in a mouse assay for nine As-contaminated soils and 1 NIST reference material (2710a). Significant differences (P < 0.05) in As IVBA were observed within and between assays indicating that different IVBA methodologies may not produce congruent data, as a result of variability in the extracting medium constituents and/or differences in the pH of gastric and intestinal phases. When results of in vivo determinations of As RBA were compared with As IVBA results, there was no significant difference in slopes of the relationships (P = 0.49-0.88) when SBRC, IVG, PBET, DIN, and UBM gastric and intestinal phase data were used. A significantly (P < 0.05) smaller y-intercept was, however, determined for the in vivo-SBRC gastric phase correlation compared to SBRC, IVG, PBET, and DIN intestinal phase, a factor that may influence prediction of As RBA, especially for soils with low As RBA. When in vivo-in vitro relationships were compared to previously derived correlations from the literature, some differences were observed. These differences may be attributed to factors affecting both in vivo and in vitro data including physiological differences in animal models (e.g., mouse versus swine), which may influence As absorption, differences in the approach used to estimate As RBA, and variability arising from subtle interoperator differences in performance of in vitro assays.

Iron amendments to reduce bioaccessible arsenic

Former sugarcane lands on the Island of Hawaii have elevated levels of soil arsenic (As) from historical use of arsenical pesticides. The bioaccessible fraction of total As (AsTOT), a measure of the potential for human As uptake by incidental ingestion of soil, is used in the assessment of human health risk and the determination of the need for remedial action. Ferric chloride plus lime and ferrous sulfate plus lime were applied to As-contaminated soils in a field plot setting to determine the potential for reducing in vitro bioaccessible As (AsIVBA) by increasing As sequestration by the formation of additional iron (Fe) oxyhydroxides. The two Fe sources performed similarly in reducing AsIVBA over a 2-year observation period, with 30-41% reduction in AsIVBA for 0.25wt% Fe dosing (dry soil basis) and 59-63% reduction for 0.5wt% Fe dosing. Addition of phosphate (PO4) to treated and untreated soils caused a significant increase in AsIVBA. Iron-treated and control soils showed more than twice the AsIVBA after the addition of 1500mgPkg(-1). The cost of in situ treatment of As-contaminated soil with ferrous sulfate plus lime to lower AsIVBA was estimated to be an order of magnitude less than excavation and landfill disposal on the Island of Hawaii, making the technology a viable alternative when remedial action objectives were based on AsIVBA levels.